Certified Global Research Member

Isomar fd.webp

Wcrc 57.webp

Key Questions Answered

Global Market Outlook
In-depth analysis of global and regional trends
Analyze and identify the major players in the market, their market share, key developments, etc.
To understand the capability of the major players based on products offered, financials, and strategies.
Identify disrupting products, companies, and trends.
To identify opportunities in the market.
Analyze the key challenges in the market.
Analyze the regional penetration of players, products, and services in the market.
Comparison of major players’ financial performance.
Evaluate strategies adopted by major players.
Recommendations

Why Choose Market Research Future?

Vigorous research methodologies for specific market.
Knowledge partners across the globe
Large network of partner consultants.
Ever-increasing/ Escalating data base with quarterly monitoring of various markets
Trusted by fortune 500 companies/startups/ universities/organizations
Large database of 5000+ markets reports.
Effective and prompt pre- and post-sales support.

Global Lactose Intolerance Treatment Market Research Report Information By Type (Lactose Intolerance, Secondary Lactose Intolerance, Congenital Lactose Intolerance), By Treatment (Food Supplements, Enzyme Lactase Supplements, Probiotics), By Form (Powder, Liquid and Tablets), By End User (Homecare and Hospitals & Clinics) - Forecast till 2030

ID: MRFR/Pharma/2581-CR | 133 Pages | Author: Rahul Gotadki| March 2019

Leading companies partner with us for data-driven Insights

Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

1 Executive Summary

2 Market Introduction

2.1 Introduction 14

2.2 Assumptions & Limitations 14

2.2.1 Assumptions 14

2.2.2 Limitations 14

2.3 Market Structure 14

3 Research Methodology

3.1 Research Process 15

3.2 Data Mining 15

3.3 Secondary Research 16

3.4 Primary Research 17

3.5 Forecasting Techniques 19

3.6 Research Methodology for Market Size Estimation 20

3.6.1 Bottom-Up Approach 21

3.6.2 Top-Down Approach 21

3.6.3 Data Triangulation 22

3.6.4 Validation 22

4 Market Dynamics

4.1 Introduction 23

4.2 Drivers 23

4.2.1 Rising Cases of Gastrointestinal Disorders 23

4.2.2 Increasing Awareness About Lactose Intolerance and Related Complications 24

4.2.3 Increased Prevalence of Lactose Intolerance 24

4.3 Restraints 25

4.3.1 Side-Effects Associated with Supplements 25

4.4 Opportunities 25

5 Market Factor Analysis

5.1 Value Chain Analysis 26

5.1.1 R&D 26

5.1.2 Manufacturing 26

5.1.3 Distribution & Sales 26

5.1.4 Post-Sales Monitoring 26

5.2 Porter’s Five Forces Model 27

5.2.1 Threat of New Entrants 27

5.2.2 Bargaining Power of Suppliers 27

5.2.3 Threat of Substitutes 28

5.2.4 Bargaining Power of Buyers 28

5.2.5 Intense Rivalry 28

5.3 Investment Opportunities 28

6 Lactose Intolerance Treatment Market, by Type

6.1 Introduction 29

6.2 Primary Lactose Intolerance 31

6.3 Secondary Lactose Intolerance 31

6.4 Congenital/Developmental Lactose Intolerance 32

7 Lactose Intolerance Treatment Market, by Treatment

7.1 Introduction 33

7.2 Food Supplements 35

7.3 Enzyme Lactase Supplements 35

7.4 Probiotics 36

8 Lactose Intolerance Treatment Market, by Form

8.1 Introduction 37

8.2 Powder 39

8.3 Liquid 39

8.4 Tablets & Capsules 40

9 Global Lactose Intolerance Treatment Market by, End User

9.1 Introduction 41

9.2 Homecare 43

9.3 Hospitals & Clinics 43

10 Global Lactose Intolerance Treatment Market, by Region

10.1 Introduction 44

10.2 Americas 46

Lactose Intolerance Treatment Market, by Type

Lactose Intolerance Treatment Market, by Treatment

Lactose Intolerance Treatment Market, by Form

10.2.1 North America 49

Lactose Intolerance Treatment Market, by Type

Lactose Intolerance Treatment Market, by Treatment

Lactose Intolerance Treatment Market, by Form

10.2.1.1 US 51

Lactose Intolerance Treatment Market, by Type

Lactose Intolerance Treatment Market, by Treatment

Lactose Intolerance Treatment Market, by Form

10.2.1.2 Canada 53

Lactose Intolerance Treatment Market, by Type

Lactose Intolerance Treatment Market, by Treatment

Lactose Intolerance Treatment Market, by Form

10.2.2 Latin America 55

Lactose Intolerance Treatment Market, by Type

Lactose Intolerance Treatment Market, by Treatment

Lactose Intolerance Treatment Market, by Form

10.3 Europe 58

Lactose Intolerance Treatment Market, by Type

Lactose Intolerance Treatment Market, by Treatment

Lactose Intolerance Treatment Market, by Form

10.3.1 Western Europe 61

Lactose Intolerance Treatment Market, by Type

Lactose Intolerance Treatment Market, by Treatment

Lactose Intolerance Treatment Market, by Form

10.3.1.1 Germany 64

Lactose Intolerance Treatment Market, by Type

Lactose Intolerance Treatment Market, by Treatment

Lactose Intolerance Treatment Market, by Form

10.3.1.2 France 66

Lactose Intolerance Treatment Market, by Type

Lactose Intolerance Treatment Market, by Treatment

Lactose Intolerance Treatment Market, by Form

10.3.1.3 UK 68

Lactose Intolerance Treatment Market, by Type

Lactose Intolerance Treatment Market, by Treatment

Lactose Intolerance Treatment Market, by Form

10.3.1.4 Italy 70

Lactose Intolerance Treatment Market, by Type

Lactose Intolerance Treatment Market, by Treatment

Lactose Intolerance Treatment Market, by Form

10.3.1.5 Spain 72

Lactose Intolerance Treatment Market, by Type

Lactose Intolerance Treatment Market, by Treatment

Lactose Intolerance Treatment Market, by Form

10.3.1.6 Rest of Western Europe 74

Lactose Intolerance Treatment Market, by Type

Lactose Intolerance Treatment Market, by Treatment

Lactose Intolerance Treatment Market, by Form

10.3.2 Eastern Europe 76

Lactose Intolerance Treatment Market, by Type

Lactose Intolerance Treatment Market, by Treatment

Lactose Intolerance Treatment Market, by Form

10.4 Asia-Pacific 78

Lactose Intolerance Treatment Market, by Type

Lactose Intolerance Treatment Market, by Treatment

Lactose Intolerance Treatment Market, by Form

10.4.1 China 81

Lactose Intolerance Treatment Market, by Type

Lactose Intolerance Treatment Market, by Treatment

Lactose Intolerance Treatment Market, by Form

10.4.2 Australia 83

Lactose Intolerance Treatment Market, by Type

Lactose Intolerance Treatment Market, by Treatment

Lactose Intolerance Treatment Market, by Form

10.4.3 Japan 85

Lactose Intolerance Treatment Market, by Type

Lactose Intolerance Treatment Market, by Treatment

Lactose Intolerance Treatment Market, by Form

10.4.4 India 87

Lactose Intolerance Treatment Market, by Type

Lactose Intolerance Treatment Market, by Treatment

Lactose Intolerance Treatment Market, by Form

10.4.5 South Korea 89

Lactose Intolerance Treatment Market, by Type

Lactose Intolerance Treatment Market, by Treatment

Lactose Intolerance Treatment Market, by Form

10.4.6 Rest of the Asia-Pacific 91

Lactose Intolerance Treatment Market, by Type

Lactose Intolerance Treatment Market, by Treatment

Lactose Intolerance Treatment Market, by Form

10.5 Middle East & Africa 93

Lactose Intolerance Treatment Market, by Type

Lactose Intolerance Treatment Market, by Treatment

Lactose Intolerance Treatment Market, by Form

10.5.1 Middle East 96

Lactose Intolerance Treatment Market, by Type

Lactose Intolerance Treatment Market, by Treatment

Lactose Intolerance Treatment Market, by Form

10.5.2 Africa 98

Lactose Intolerance Treatment Market, by Type

Lactose Intolerance Treatment Market, by Treatment

Lactose Intolerance Treatment Market, by Form

11 Competitive Landscape

11.1 Introduction 100

11.2 Company Share Analysis 100

12 Company Profiles

12.1 Johnson & Johnson Services, Inc. 101

12.1.1 Company Overview 101

12.1.2 Financial Overview 101

12.1.3 Products/Services Offered 102

12.1.4 Key Developments 102

12.1.5 SWOT Analysis 102

12.1.6 Key Strategies 102

12.2 Nestlé 103

12.2.1 Company Overview 103

12.2.2 Financial Overview 103

12.2.3 Products/Services Offered 104

12.2.4 Key Developments 104

12.2.5 SWOT Analysis 104

12.2.6 Key Strategies 105

12.3 Abbott 106

12.3.1 Company Overview 106

12.3.2 Financial Overview 106

12.3.3 Products/Services Offered 106

12.3.4 Key Developments 107

12.3.5 SWOT Analysis 107

12.3.6 Key Strategies 107

12.4 Deerland Enzymes, Inc. 108

12.4.1 Company Overview 108

12.4.2 Financial Overview 108

12.4.3 Products/Services Offered 108

12.4.4 Key Developments 108

12.4.5 SWOT Analysis 109

12.4.6 Key Strategies 109

12.5 Ritter Pharmaceuticals 110

12.5.1 Company Overview 110

12.5.2 Financial Overview 110

12.5.3 Products/Services Offered 110

12.5.4 Key Developments 110

12.5.5 SWOT Analysis 111

12.5.6 Key Strategies 111

12.6 Guardian Drug Company 112

12.6.1 Company Overview 112

12.6.2 Financial Overview 112

12.6.3 Products/Services Offered 112

12.6.4 Key Developments 112

12.6.5 SWOT Analysis 113

12.6.6 Key Strategies 113

12.7 Novozymes 114

12.7.1 Company Overview 114

12.7.2 Financial Overview 114

12.7.3 Products/Services Offered 114

12.7.4 Key Developments 115

12.7.5 SWOT Analysis 115

12.7.6 Key Strategies 115

12.8 Cargill, Incorporated 116

12.8.1 Company Overview 116

12.8.2 Financial Overview 116

12.8.3 Products/Services Offered 116

12.8.4 Key Developments 116

12.8.5 SWOT Analysis 117

12.8.6 Key Strategies 117

12.9 Arla Foods 118

12.9.1 Company Overview 118

12.9.2 Financial Overview 118

12.9.3 Products/Services Offered 119

12.9.4 Key Developments 119

12.9.5 SWOT Analysis 119

12.9.6 Key Strategies 120

12.10 Dean Foods 121

12.10.1 Company Overview 121

12.10.2 Financial Overview 121

12.10.3 Products/Services Offered 121

12.10.4 Key Developments 122

12.10.5 SWOT Analysis 122

12.10.6 Key Strategies 122

13 Appendix

13.1 References 123

13.2 Related Reports 123

14 List of Tables

TABLE 1 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS 18

TABLE 2 GLOBAL LACTOSE INTOLERANCE TREATMENT, BY TYPE 2023–2030 (USD MILLION) 30

TABLE 3 GLOBAL LACTOSE INTOLERANCE TREATMENT MARKET FOR PRIMARY LACTOSE INTOLERANCE, BY REGION 2023 & 2030 (USD MILLION) 31

TABLE 4 GLOBAL LACTOSE INTOLERANCE TREATMENT MARKET FOR SECONDARY LACTOSE INTOLERANCE, BY REGION 2023 & 2030 (USD MILLION) 31

TABLE 5 GLOBAL LACTOSE INTOLERANCE TREATMENT MARKET FOR CONGENITAL/DEVELOPMENTAL LACTOSE INTOLERANCE, BY REGION 2023 & 2030 (USD MILLION) 32

TABLE 6 GLOBAL LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT 2023–2030 (USD MILLION) 34

TABLE 7 GLOBAL LACTOSE INTOLERANCE TREATMENT MARKET FOR FOOD SUPPLEMENT, BY REGION 2023 & 2030 (USD MILLION) 35

TABLE 8 GLOBAL LACTOSE INTOLERANCE TREATMENT MARKET FOR ENZYME LACTASE SUPPLEMENTS, BY REGION 2023 & 2030 (USD MILLION) 35

TABLE 9 GLOBAL LACTOSE INTOLERANCE TREATMENT MARKET FOR PROBIOTICS, BY REGION 2023 & 2030 (USD MILLION) 36

TABLE 10 GLOBAL LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM 2023–2030 (USD MILLION) 38

TABLE 11 GLOBAL LACTOSE INTOLERANCE TREATMENT MARKET FOR POWDER, BY REGION 2023–2030 (USD MILLION) 39

TABLE 12 GLOBAL LACTOSE INTOLERANCE TREATMENT MARKET FOR LIQUID, BY REGION 2023–2030 (USD MILLION) 39

TABLE 13 GLOBAL LACTOSE INTOLERANCE TREATMENT MARKET FOR TABLETS/CAPSULES, BY REGION 2023–2030 (USD MILLION) 40

TABLE 14 GLOBAL LACTOSE INTOLERANCE TREATMENT MARKET, BY END USER 2023–2030 (USD MILLION) 42

TABLE 15 GLOBAL LACTOSE INTOLERANCE TREATMENT MARKET FOR HOME CARE, BY REGION 2023–2030 (USD MILLION) 43

TABLE 16 GLOBAL LACTOSE INTOLERANCE TREATMENT MARKET FOR HOSPITAL & CLINICS, BY REGION 2023–2030 (USD MILLION) 43

TABLE 17 GLOBAL LACTOSE INTOLERANCE TREATMENT MARKET, BY REGION 2023–2030 (USD MILLION) 44

TABLE 18 AMERICAS: LACTOSE INTOLERANCE TREATMENT MARKET, BY REGION 2023–2030 (USD MILLION) 46

TABLE 19 AMERICAS: LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE 2023–2030 (USD MILLION) 47

TABLE 20 AMERICAS: LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT 2023–2030 (USD MILLION) 47

TABLE 21 AMERICAS: LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM 2023–2030 (USD MILLION) 48

TABLE 22 AMERICAS: LACTOSE INTOLERANCE TREATMENT MARKET, BY END USER 2023–2030 (USD MILLION) 48

TABLE 23 NORTH AMERICA: LACTOSE INTOLERANCE TREATMENT MARKET, BY COUNTRY 2023–2030 (USD MILLION) 49

TABLE 24 NORTH AMERICA: LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE 2023–2030 (USD MILLION) 49

TABLE 25 NORTH AMERICA: LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT 2023–2030 (USD MILLION) 50

TABLE 26 NORTH AMERICA: LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM 2023–2030 (USD MILLION) 50

TABLE 27 NORTH AMERICA: LACTOSE INTOLERANCE TREATMENT MARKET, BY END USER 2023–2030 (USD MILLION) 51

TABLE 28 US: LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE 2023–2030 (USD MILLION) 51

TABLE 29 US: LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT 2023–2030 (USD MILLION) 52

TABLE 30 US: LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM 2023–2030 (USD MILLION) 52

TABLE 31 US: LACTOSE INTOLERANCE TREATMENT MARKET, BY END USER 2023–2030 (USD MILLION) 53

TABLE 32 CANADA: LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE 2023–2030 (USD MILLION) 53

TABLE 33 CANADA: LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT 2023–2030 (USD MILLION) 54

TABLE 34 CANADA: LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM 2023–2030 (USD MILLION) 54

TABLE 35 CANADA: LACTOSE INTOLERANCE TREATMENT MARKET, BY END USER 2023–2030 (USD MILLION) 55

TABLE 36 LATIN AMERICA: LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE 2023–2030 (USD MILLION) 55

TABLE 37 LATIN AMERICA: LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT 2023–2030 (USD MILLION) 56

TABLE 38 LATIN AMERICA: LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM 2023–2030 (USD MILLION) 56

TABLE 39 LATIN AMERICA: LACTOSE INTOLERANCE TREATMENT MARKET, BY END USER 2023–2030 (USD MILLION) 57

TABLE 40 EUROPE: LACTOSE INTOLERANCE TREATMENT MARKET, BY REGION 2023–2030 (USD MILLION) 58

TABLE 41 EUROPE: LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE 2023–2030 (USD MILLION) 59

TABLE 42 EUROPE: LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT 2023–2030 (USD MILLION) 59

TABLE 43 EUROPE: LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM 2023–2030 (USD MILLION) 60

TABLE 44 EUROPE: LACTOSE INTOLERANCE TREATMENT MARKET, BY END USER 2023–2030 (USD MILLION) 60

TABLE 45 WESTERN EUROPE: LACTOSE INTOLERANCE TREATMENT MARKET, BY COUNTRY 2023–2030 (USD MILLION) 61

TABLE 46 WESTERN EUROPE: LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE 2023–2030 (USD MILLION) 62

TABLE 47 WESTERN EUROPE: LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT 2023–2030 (USD MILLION) 62

TABLE 48 WESTERN EUROPE: LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM 2023–2030 (USD MILLION) 63

TABLE 49 WESTERN EUROPE: LACTOSE INTOLERANCE TREATMENT MARKET, BY END USER 2023–2030 (USD MILLION) 63

TABLE 50 GERMANY: LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE 2023–2030 (USD MILLION) 64

TABLE 51 GERMANY: LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT 2023–2030 (USD MILLION) 64

TABLE 52 GERMANY: LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM 2023–2030 (USD MILLION) 65

TABLE 53 GERMANY: LACTOSE INTOLERANCE TREATMENT MARKET, BY END USER 2023–2030 (USD MILLION) 65

TABLE 54 FRANCE: LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE 2023–2030 (USD MILLION) 66

TABLE 55 FRANCE: LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT 2023–2030 (USD MILLION) 66

TABLE 56 FRANCE: LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM 2023–2030 (USD MILLION) 67

TABLE 57 FRANCE: LACTOSE INTOLERANCE TREATMENT MARKET, BY END USER 2023–2030 (USD MILLION) 67

TABLE 58 UK: LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE 2023–2030 (USD MILLION) 68

TABLE 59 UK: LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT 2023–2030 (USD MILLION) 68

TABLE 60 UK: LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM 2023–2030 (USD MILLION) 69

TABLE 61 UK: LACTOSE INTOLERANCE TREATMENT MARKET, BY END USER 2023–2030 (USD MILLION) 69

TABLE 62 ITALY: LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE 2023–2030 (USD MILLION) 70

TABLE 63 ITALY: LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT 2023–2030 (USD MILLION) 70

TABLE 64 ITALY: LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM 2023–2030 (USD MILLION) 71

TABLE 65 ITALY: LACTOSE INTOLERANCE TREATMENT MARKET, BY END USER 2023–2030 (USD MILLION) 71

TABLE 66 SPAIN: LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE 2023–2030 (USD MILLION) 72

TABLE 67 SPAIN: LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT 2023–2030 (USD MILLION) 72

TABLE 68 SPAIN: LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM 2023–2030 (USD MILLION) 73

TABLE 69 SPAIN: LACTOSE INTOLERANCE TREATMENT MARKET, BY END USER 2023–2030 (USD MILLION) 73

TABLE 70 REST OF WESTERN EUROPE: LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE 2023–2030 (USD MILLION) 74

TABLE 71 REST OF WESTERN EUROPE: LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT 2023–2030 (USD MILLION) 74

TABLE 72 REST OF WESTERN EUROPE: LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM 2023–2030 (USD MILLION) 75

TABLE 73 REST OF WESTERN EUROPE: LACTOSE INTOLERANCE TREATMENT MARKET, BY END USER 2023–2030 (USD MILLION) 75

TABLE 74 EASTERN EUROPE: LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE 2023–2030 (USD MILLION) 76

TABLE 75 EASTERN EUROPE: LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT 2023–2030 (USD MILLION) 76

TABLE 76 EASTERN EUROPE: LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM 2023–2030 (USD MILLION) 77

TABLE 77 EASTERN EUROPE: LACTOSE INTOLERANCE TREATMENT MARKET, BY END USER 2023–2030 (USD MILLION) 77

TABLE 78 ASIA-PACIFIC: LACTOSE INTOLERANCE TREATMENT MARKET, BY COUNTRY 2023–2030 (USD MILLION) 78

TABLE 79 ASIA-PACIFIC: LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE 2023–2030 (USD MILLION) 79

TABLE 80 ASIA-PACIFIC: LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT 2023–2030 (USD MILLION) 79

TABLE 81 ASIA-PACIFIC: LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM 2023–2030 (USD MILLION) 80

TABLE 82 ASIA-PACIFIC: LACTOSE INTOLERANCE TREATMENT MARKET, BY END USER 2023–2030 (USD MILLION) 80

TABLE 83 CHINA: LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE 2023–2030 (USD MILLION) 81

TABLE 84 CHINA: LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT 2023–2030 (USD MILLION) 81

TABLE 85 CHINA: LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM 2023–2030 (USD MILLION) 82

TABLE 86 CHINA: LACTOSE INTOLERANCE TREATMENT MARKET, BY END USER 2023–2030 (USD MILLION) 82

TABLE 87 AUSTRALIA: LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE 2023–2030 (USD MILLION) 83

TABLE 88 AUSTRALIA: LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT 2023–2030 (USD MILLION) 83

TABLE 89 AUSTRALIA: LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM 2023–2030 (USD MILLION) 84

TABLE 90 AUSTRALIA: LACTOSE INTOLERANCE TREATMENT MARKET, BY END USER 2023–2030 (USD MILLION) 84

TABLE 91 JAPAN: LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE 2023–2030 (USD MILLION) 85

TABLE 92 JAPAN: LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT 2023–2030 (USD MILLION) 85

TABLE 93 JAPAN: LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM 2023–2030 (USD MILLION) 86

TABLE 94 JAPAN: LACTOSE INTOLERANCE TREATMENT MARKET, BY END USER 2023–2030 (USD MILLION) 86

TABLE 95 INDIA: LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE 2023–2030 (USD MILLION) 87

TABLE 96 INDIA: LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT 2023–2030 (USD MILLION) 87

TABLE 97 INDIA: LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM 2023–2030 (USD MILLION) 88

TABLE 98 INDIA: LACTOSE INTOLERANCE TREATMENT MARKET, BY END USER 2023–2030 (USD MILLION) 88

TABLE 99 SOUTH KOREA: LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE 2023–2030 (USD MILLION) 89

TABLE 100 SOUTH KOREA: LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT 2023–2030 (USD MILLION) 89

TABLE 101 SOUTH KOREA: LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM 2023–2030 (USD MILLION) 90

TABLE 102 SOUTH KOREA: LACTOSE INTOLERANCE TREATMENT MARKET, BY END USER 2023–2030 (USD MILLION) 90

TABLE 103 REST OF THE ASIA-PACIFIC: LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE 2023–2030 (USD MILLION) 91

TABLE 104 REST OF THE ASIA-PACIFIC: LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT 2023–2030 (USD MILLION) 91

TABLE 105 REST OF THE ASIA-PACIFIC: LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM 2023–2030 (USD MILLION) 92

TABLE 106 REST OF THE ASIA-PACIFIC: LACTOSE INTOLERANCE TREATMENT MARKET, BY END USER 2023–2030 (USD MILLION) 92

TABLE 107 MIDDLE EAST & AFRICA: LACTOSE INTOLERANCE TREATMENT MARKET, BY REGION 2023–2030 (USD MILLION) 93

TABLE 108 MIDDLE EAST & AFRICA: LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE 2023–2030 (USD MILLION) 94

TABLE 109 MIDDLE EAST & AFRICA: LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT 2023–2030 (USD MILLION) 94

TABLE 110 MIDDLE EAST & AFRICA: LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM 2023–2030 (USD MILLION) 95

TABLE 111 MIDDLE EAST & AFRICA: LACTOSE INTOLERANCE TREATMENT MARKET, BY END USER 2023–2030 (USD MILLION) 95

TABLE 112 MIDDLE EAST: LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE 2023–2030 (USD MILLION) 96

TABLE 113 MIDDLE EAST: LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT 2023–2030 (USD MILLION) 96

TABLE 114 MIDDLE EAST: LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM 2023–2030 (USD MILLION) 97

TABLE 115 MIDDLE EAST: LACTOSE INTOLERANCE TREATMENT MARKET, BY END USER 2023–2030 (USD MILLION) 97

TABLE 116 AFRICA: LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE 2023–2030 (USD MILLION) 98

TABLE 117 AFRICA: LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT 2023–2030 (USD MILLION) 98

TABLE 118 AFRICA: LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM 2023–2030 (USD MILLION) 99

TABLE 119 AFRICA: LACTOSE INTOLERANCE TREATMENT MARKET, BY END USER 2023–2030 (USD MILLION) 99

15 List of Figures

FIGURE 1 MARKET SYNOPSIS 13

FIGURE 2 GLOBAL LACTOSE INTOLERANCE TREATMENT MARKET: MARKET STRUCTURE 14

FIGURE 3 PRIMARY RESPONDENT’S BREAKDOWN 18

FIGURE 4 BOTTOM-UP AND TOP-DOWN APPROACH 20

FIGURE 5 MARKET DYNAMICS: ANALYSIS OF THE GLOBAL LACTOSE INTOLERANCE TREATMENT MARKET 23

FIGURE 6 VALUE CHAIN: GLOBAL LACTOSE INTOLERANCE TREATMENT MARKET 26

FIGURE 7 PORTER’S FIVE FORCES ANALYSIS: GLOBAL LACTOSE INTOLERANCE TREATMENT MARKET 27

FIGURE 8 GLOBAL LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE 2023 (%) 29

FIGURE 9 GLOBAL LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE 2023 & 2030 (USD MILLION) 30

FIGURE 10 GLOBAL LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT 2023 (%) 33

FIGURE 11 GLOBAL LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT 2023 & 2030 (USD MILLION) 34

FIGURE 12 GLOBAL LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM 2023 (%) 37

FIGURE 13 GLOBAL LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM 2023–2030 (USD MILLION) 38

FIGURE 14 GLOBAL LACTOSE INTOLERANCE TREATMENT MARKET, BY END USER 2023 (%) 41

FIGURE 15 GLOBAL LACTOSE INTOLERANCE TREATMENT MARKET, BY END USER 2023–2030 (USD MILLION) 42

FIGURE 16 GLOBAL LACTOSE INTOLERANCE TREATMENT MARKET, BY REGION2023–2030 (USD MILLION) 45

FIGURE 17 GLOBAL LACTOSE INTOLERANCE TREATMENT MARKET, BY REGION 2023 (%) 45

FIGURE 18 AMERICAS: LACTOSE INTOLERANCE TREATMENT MARKET, BY REGION 2023 (%) 46

FIGURE 19 NORTH AMERICA: LACTOSE INTOLERANCE TREATMENT MARKET, BY COUNTRY 2023 (%) 49

FIGURE 20 EUROPE: LACTOSE INTOLERANCE TREATMENT MARKET, BY REGION 2023 (%) 58

FIGURE 21 WESTERN EUROPE: LACTOSE INTOLERANCE TREATMENT MARKET, BY COUNTRY 2023 (%) 61

FIGURE 22 ASIA-PACIFIC: LACTOSE INTOLERANCE TREATMENT MARKET, BY COUNTRY 2023 (%) 78

FIGURE 23 MIDDLE EAST & AFRICA: LACTOSE INTOLERANCE TREATMENT MARKET, BY REGION 2023 (%) 93

FIGURE 24 GLOBAL LACTOSE INTOLERANCE TREATMENT MAJOR PLAYERS MARKET SHARE ANALYSIS, 2023 (%) 100

Purchase Option
	Single User	$ 4,950
	Multiuser License	$ 5,950
	Enterprise User	$ 7,250
Compare Licenses

Tailored for You

Dedicated Research on any specifics segment or region.
Focused Research on specific players in the market.
Custom Report based only on your requirements.
Flexibility to add or subtract any chapter in the study.
Historic data from 2014 and forecasts outlook till 2040.
Flexibility of providing data/insights in formats (PDF, PPT, Excel).
Provide cross segmentation in applicable scenario/markets.

Related Reports

Malabsorption Syndrome Market Research Report– Global Forecast till 2030

US Malabsorption Syndrome Market

Press Release

pr-img

The High Rate of Lactose Intolerance is Anticipated to Fuel the Global Lactose Intolerance Treatm...

FEATURES	LICENCE TYPE
FEATURES	Single User	Multiuser Licence	Enterprise User
Price	$ 4,950	$ 5,950	$ 7,250
Maximum User Access Limit	1 User	Upto 10 Users	Unrestricted Access Throughout The Organization.
Free Customization
Direct access to the Analyst
Deliverable Format
Deliverable Format
Platform Access
Discount on Your Next Purchase	10%	15%	10%
Printable Versions

© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)